Instituto Nacional de Salud Pública. Cuernavaca, Morelos, México.
Brown University. Providence, Rhode Island, USA.
Salud Publica Mex. 2019 Sep-Oct;61(5):692-697. doi: 10.21149/10411.
Bisphenol A (BPA), found in plastics and epoxy resins, is one of the most studied chemicals. BPA is regarded as an endocrine disruptor and has been related to adverse health effects in humans. However, some regulatory agencies around the world have concluded that BPA is safe at current human exposure levels. As the scientific community attempts to settle the debate on BPA's health effects, regulatory agencies have been put into a challenging public health policy situation. The United States has implemented no regulatory actions due to safety concerns, while Europe has used the precautionary principle to guide its regulation in the face of scientific uncertainty. In this paper, we explore the debate surrounding BPA regulation and the possibility for countries to introduce guidelines, using Mexico as an example. Policy change determinants analysis suggest that countries can and should impose regulations on BPA.
双酚 A（BPA）存在于塑料和环氧树脂中，是研究最多的化学物质之一。BPA 被认为是一种内分泌干扰物，与人类的不良健康影响有关。然而，世界上一些监管机构得出结论认为，在当前人类接触水平下，BPA 是安全的。随着科学界试图解决 BPA 对健康影响的争论，监管机构陷入了具有挑战性的公共卫生政策局面。由于安全问题，美国没有采取任何监管行动，而欧洲则在面对科学不确定性时使用预防原则来指导其监管。本文以墨西哥为例，探讨了围绕 BPA 监管的争论以及各国制定指南的可能性。政策变更决定因素分析表明，各国可以而且应该对 BPA 实施监管。
